Records containing: Psoriasis Vulgaris
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2017-03-03Efficacy and Safety of HAT1, a Novel Topical Therapeutic: An Open Label Pilot Study of HAT1 Compared to Calcipotriol in Patients With Chronic Plaque Psoriasis
-
CLINICAL_TRIALS study record update · 2017-02-15Study to Assess Pharmacodynamics, Clinical Effects, Safety and Pharmacokinetics of TAB08 in Patients With Psoriasis Vulgaris, Not Adequately Controlled With Current Concomitant Therapy
-
CLINICAL_TRIALS study record update · 2016-12-28A Clinical Trial Gathering Insight of Patient Reported Factors That Influence Preference Following Once Daily Topical Treatment With LEO 90100 Aerosol Foam and Daivobet® Gel in Subjects With Psoriasis Vulgaris
-
CLINICAL_TRIALS study record update · 2016-12-13Effect of Photochemotherapy on Cardiometabolic Markers in Patients With Psoriasis With and Without Atherosclerosis
-
CLINICAL_TRIALS study record update · 2016-09-16A Phase 2 Maximal Use Systemic Exposure (MUSE) Study Evaluating the Safety and Efficacy of LEO 90100 Used Once Daily in Subjects With Extensive Psoriasis Vulgaris
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2016-09-16An International Prospective, Double-blind, Placebo-controlled Phase III Randomised Controlled Trial (RCT) in Patients With Moderate to Severe Psoriasis Are Treated With Subcutaneous (s.c.) Methotrexate Using an Optimized Treatment Schedule.
-
CLINICAL_TRIALS study record update · 2016-06-14LP0058-1005 - A Phase I, Open-Label, Four-Way Crossover and Food-Effect Study of LEO 32731 in Healthy Subjects When Administered as an Immediate and Modified Release Formulation
-
CLINICAL_TRIALS study record update · 2016-06-09A Phase 1, Single- Center, Randomized, Double-blind, Vehicle And Active Comparator-controlled Trial To Evaluate The Antipsoriatic Activity And Safety Of A Topically Applied Pf-06263276 Formulation In A Psoriasis Plaque Test
-
CLINICAL_TRIALS study record update · 2016-05-09LEO 90100 Compared to Vehicle in Subjects With Psoriasis Vulgaris
-
CLINICAL_TRIALS study record update · 2016-05-02LEO 90100 Aerosol Foam Compared to Calcipotriol Plus Betamethasone Dipropionate Gel in Subjects With Psoriasis Vulgaris
-
CLINICAL_TRIALS study record update · 2016-04-04Pilot Study on the Safety and Efficacy of Botulinum Toxin Injections in the Treatment of Psoriasis Vulgaris.
-
CLINICAL_TRIALS study record update · 2016-03-22Pharmacogenomics Study on Treatment of Psoriasis Vulgaris by Acitretin Capsules
-
CLINICAL_TRIALS study record update · 2016-03-22Pharmacogenomics Study on Treatment of Psoriasis Vulgaris by Methotrexate
-
CLINICAL_TRIALS study record update · 2016-02-24A Psoriasis Plaque Test Study With LEO 90100 Cutaneous Spray, Ointment, in Psoriasis Vulgaris
-
CLINICAL_TRIALS study record update · 2015-12-09ClinicalTrials.gov study NCT01536938
-
CLINICAL_TRIALS study record update · 2015-12-09A Phase 2 Study Comparing Treatment With LEO 90100 With Calcipotriol Plus Betamethasone Ointment, LEO 90100 Vehicle and Ointment Vehicle in Subjects With Psoriasis Vulgaris.
-
CLINICAL_TRIALS study record update · 2015-11-25A Phase 2b, Multi-site, Randomized, Double-blind, Vehicle-controlled, Parallel-group Study Of The Efficacy, Safety, Local Tolerability And Pharmacokinetics Of 2 Dose Strengths And 2 Regimens Of Tofacitinib Ointment In Subjects With Chronic Plaque Psoriasis.
-
CLINICAL_TRIALS study record update · 2015-11-18Monocenter, Randomized, Double Blinded, Intraindividual, Exploratory Study of Effectiveness and Safety of 3 Months Treatment With 2 Peak Intensities of 453nm Blue Light for the Treatment of Mild Plaque Type Psoriasis Vulgaris
-
CLINICAL_TRIALS study record update · 2015-07-08A Study to Assess Safety and Efficacy of Umbilical Cord Derived Mesenchymal Stem Cells (UC-MSCs) in Patients With Psoriasis Vulgaris
-
CLINICAL_TRIALS study record update · 2014-08-12A Multi-center, Double-blinded, Randomized, Placebo-controlled, Phase II Study to Evaluate the Safety, Tolerability and Efficacy of a Topical Application of DLX105 Onto Lesional Skin in Patients With Mild-to-moderate Psoriasis Vulgaris
-
CLINICAL_TRIALS study record update · 2014-06-04Investigator Initiated Study for Optimal Maintenance Treatment With Calcipotriol /Betamethasone Dipropionate Gel in Korean Patients With Psoriasis Vulgaris
-
CLINICAL_TRIALS study record update · 2014-03-14Mechanistic Study of Indigo Naturalis in Treating Psoriasis: Local or Systemic Manipulation of Inflammation and Induction of Immunoregulation
-
CLINICAL_TRIALS study record update · 2014-03-13CARDIOVASCULAR RISK FACTORS IN A SPANISH POPULATION OF PATIENTS WITH MODERATE-TO-SEVERE PSORIASIS VULGARIS, WITH OR WITHOUT ARTHRITIS, TREATED WITH ANTI-TNF IN REAL CLINICAL PRACTICE. ANALYSIS OF THE INFLUENCE OF METABOLIC SYNDROME ON TREATMENT EFFICACY.
-
CLINICAL_TRIALS study record update · 2013-12-30ClinicalTrials.gov study NCT01768013
-
CLINICAL_TRIALS study record update · 2013-12-30A Plaque Test Study With LEO 35299 in Psoriasis Vulgaris